These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 10809201)

  • 1. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
    Agostini D; Belin A; Amar MH; Darlas Y; Hamon M; Grollier G; Potier JC; Bouvard G
    J Nucl Med; 2000 May; 41(5):845-51. PubMed ID: 10809201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.
    Maunoury C; Acar P; Sidi D
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1651-6. PubMed ID: 14504829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
    Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Eur Heart J; 2007 Apr; 28(8):989-95. PubMed ID: 17409109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy.
    Toyama T; Aihara Y; Iwasaki T; Hasegawa A; Suzuki T; Nagai R; Endo K; Hoshizaki H; Oshima S; Taniguchi K
    J Nucl Med; 1999 Feb; 40(2):217-23. PubMed ID: 10025826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.
    Lotze U; Kaepplinger S; Kober A; Richartz BM; Gottschild D; Figulla HR
    J Nucl Med; 2001 Jan; 42(1):49-54. PubMed ID: 11197980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.
    Toyama T; Hoshizaki H; Seki R; Isobe N; Adachi H; Naito S; Oshima S; Taniguchi K
    J Nucl Med; 2003 Oct; 44(10):1604-11. PubMed ID: 14530474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of short-term carvedilol on the cardiac sympathetic activity assessed by 123I-MIBG scintigraphy.
    Miranda SM; Mesquita ET; Dohmann HF; Azevedo JC; Barbirato GB; Freire Fde L; Ribeiro ML; Nóbrega AC; Coimbra A; Mesquita CT
    Arq Bras Cardiol; 2010 Mar; 94(3):308-12, 328-32. PubMed ID: 20730258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart.
    Merlet P; Pouillart F; Dubois-Randé JL; Delahaye N; Fumey R; Castaigne A; Syrota A
    J Nucl Med; 1999 Feb; 40(2):224-31. PubMed ID: 10025827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of carvedilol on cardiac function and cardiac adrenergic neuronal damage in rats with dilated cardiomyopathy.
    Watanabe K; Takahashi T; Nakazawa M; Wahed MI; Fuse K; Tanabe N; Kodama M; Aizawa Y; Ashino H; Tazawa S
    J Nucl Med; 2002 Apr; 43(4):531-5. PubMed ID: 11937598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prediction of cardiac sympathetic nerve activity and cardiac functional outcome after treatment in patients with dilated cardiomyopathy: examination using dobutamine gated blood pool scintigraphy].
    Kasama S; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Iwasaki T; Suzuki T; Nagai R
    J Cardiol; 2000 Jul; 36(1):29-35. PubMed ID: 10929263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.
    Gerson MC; Craft LL; McGuire N; Suresh DP; Abraham WT; Wagoner LE
    J Nucl Cardiol; 2002; 9(6):608-15. PubMed ID: 12466785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of cardiac neuronal function in childhood dilated cardiomyopathy: an 123I-MIBG scintigraphic study.
    Maunoury C; Agostini D; Acar P; Antonietti T; Sidi D; Bouvard G; Kachaner J; Barritault L
    J Nucl Med; 2000 Mar; 41(3):400-4. PubMed ID: 10716309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure.
    Chizzola PR; Gonçalves de Freitas HF; Marinho NV; Mansur JA; Meneghetti JC; Bocchi EA
    Int J Cardiol; 2006 Jan; 106(1):29-34. PubMed ID: 16321662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy patients.
    Ohshima S; Isobe S; Izawa H; Nanasato M; Ando A; Yamada A; Yamada K; Kato TS; Obata K; Noda A; Nishizawa T; Kato K; Nagata K; Okumura K; Murohara T; Yokota M
    J Am Coll Cardiol; 2005 Dec; 46(11):2061-8. PubMed ID: 16325043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy.
    Merlet P; Benvenuti C; Moyse D; Pouillart F; Dubois-Randé JL; Duval AM; Loisance D; Castaigne A; Syrota A
    J Nucl Med; 1999 Jun; 40(6):917-23. PubMed ID: 10452306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of therapy for dilated cardiomyopathy with heart failure by iodine-123 metaiodobenzylguanidine imaging: comparison with heart rate variability power spectral analysis].
    Li S; Ikeda J; Takita T; Sekiguchi Y; Demachi J; Chikama H; Goto A; Shirato K
    J Cardiol; 1998 Nov; 32(5):323-9. PubMed ID: 9864689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Tange S; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Nov; 45(11):1878-84. PubMed ID: 15534058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
    Naya M; Tsukamoto T; Morita K; Katoh C; Nishijima K; Komatsu H; Yamada S; Kuge Y; Tamaki N; Tsutsui H
    J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodine-123 MIBG imaging before treatment of heart failure with carvedilol to predict improvement of left ventricular function and exercise capacity.
    Choi JY; Lee KH; Hong KP; Kim BT; Seo JD; Lee WR; Lee SH
    J Nucl Cardiol; 2001; 8(1):4-9. PubMed ID: 11182704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.